Jubilant Pharmova Fact Sheet, Jubilant Pharmova Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Jubilant Pharmova Fact Sheet    (JUBOL)


Revealed: How Fund Managers Spot Winning Stocks


Here is the latest financial fact sheet of Jubilant Pharmova. For more details, see the Jubilant Pharmova quarterly results and Jubilant Pharmova share price and chart. For a sector overview, read our pharmaceuticals sector report.

JUBILANT PHARMOVA Price History

Price Rs 696.9
Mkt Cap Rs m 111,003
Vol '000 56.4
P/E X 16.0
P/CF X 8.2
EPS (TTM) Rs 43.5
% ch % -2.6
No. of shares m 159.28
% ch week % -1.3
% ch 1-mth % -6.4
% ch 12-mth % -7.0
52 week H/L Rs 1,046.8/635.1
(As on Jul 23, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

JUBILANT PHARMOVA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
JUBILANT PHARMOVA  EQUITY SHARE DATA
High Rs4558301,039898727 
Low Rs138294600617230 
Sales per share (Unadj.) Rs351.9358.9469.5572.0574.7 
Earnings per share (Unadj.) Rs24.336.139.836.256.4 
Diluted earnings per shareRs24.336.139.836.256.4 
Cash flow per share (Unadj.) Rs46.154.465.959.585.4 
Dividends per share (Unadj.) Rs3.003.003.004.505.00 
Adj. dividends per shareRs3.003.003.004.505.00 
Dividend yield (eoy) %1.00.50.40.61.0 
Book value per share (Unadj.) Rs186.2215.7256.6301.9351.8 
Adj. book value per shareRs186.2215.7256.6301.9351.8 
Shares outstanding (eoy) m159.28159.28159.28159.28159.28 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.81.61.71.30.8 
Avg P/E ratio x12.215.620.620.98.5 
P/CF ratio (eoy) x6.410.312.412.75.6 
Price / Book Value ratio x1.62.63.22.51.4 
Dividend payout %12.48.37.512.48.9 
Avg Mkt Cap Rs m47,22789,528130,531120,69176,220 
No. of employees `000NANANANANA 
Total wages/salary Rs m11,25112,30915,55919,26021,277 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
JUBILANT PHARMOVA  INCOME DATA
Net Sales Rs m56,05057,16574,77991,10891,544 
Other income Rs m134249400357474 
Total revenues Rs m56,18357,41475,17991,46692,018 
Gross profit Rs m12,46913,45315,18414,58819,124 
Depreciation Rs m3,4672,9144,1503,7094,619 
Interest Rs m3,7143,4112,8432,1982,874 
Profit before tax Rs m5,4227,3768,5919,03812,105 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,5541,6302,2473,2683,123 
Profit after tax Rs m3,8685,7466,3445,7708,982 
Gross profit margin %22.223.520.316.020.9 
Effective tax rate %28.722.126.236.225.8 
Net profit margin %6.910.18.56.39.8 
JUBILANT PHARMOVA  BALANCE SHEET DATA
Current assets Rs m28,75329,48131,89845,84850,383 
Current liabilities Rs m24,64416,84020,04720,89726,190 
Net working cap to sales %7.322.115.827.426.4 
Current ratio x1.21.81.62.21.9 
Inventory Days Days10101077 
Debtors Days Days6264555152 
Net fixed assets Rs m58,64459,50662,67467,34272,721 
Share capital Rs m155156156159159 
"Free" reserves Rs m29,50734,20040,70847,92955,880 
Net worth Rs m29,66334,35640,86448,08956,039 
Long term debt Rs m30,13235,05030,47842,42937,397 
Total assets Rs m87,39788,98794,572113,190123,104 
Interest coverage x2.53.24.05.15.2 
Debt to equity ratio x1.01.00.70.90.7 
Sales to assets ratio x0.60.60.80.80.7 
Return on assets %8.710.39.77.09.6 
Return on equity %13.016.715.512.016.0 
Return on capital %15.315.516.012.416.0 
Exports to sales %22.00000 
Imports to sales %15.113.616.118.914.8 
Exports (fob) Rs m12,3390000 
Imports (cif) Rs m8,4677,76212,04417,22713,515 
Fx inflow Rs m12,34410,88114,40212,42215,515 
Fx outflow Rs m9,4137,76212,04417,22713,515 
Net fx Rs m2,9313,1192,358-4,8052,000 
JUBILANT PHARMOVA  CASH FLOW
From Operations Rs m 10,989 12,685 13,032 11,215 15,429 
From Investments Rs m -3,125 -4,504 -6,177 -10,118 -3,270 
From Financial Activity Rs m -8,427 -6,859 -9,011 6,574 -10,504 
Net Cashflow Rs m -524 1,172 -2,123 7,612 2,254 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 46.5%
Foreign collaborators 4.2%
Indian inst/Mut Fund 26.6%
FIIs 24.8%
ADR/GDR 0.0%
Free float 49.3%
Shareholders 87,493
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Bhartiagram , Jyotiba Phoolay Nagar, Gajraula - 244223
E-MAIL invstors@jubl.com WEB www.jubl.com
TEL +91-5924-252351-60 FAX 05924-252352
SECTOR PHARMACEUTICALS GROUP Jubilant Bhartia
TR AGENT Alankit Assignments Ltd., 205-208 Anarkali Complex, Jhandewala Extension
AUDITOR K. N. Gutgutia & Co.
CHM: Shyam S. Bhartia COMP SEC: Lalit Jain YEAR OF INC: 1978 BSE CODE: 530019 FV (Rs): 1 DIV YIELD (%): 0.7

Read: JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   BERYL DRUGS  ANG LIFESCIENCES INDIA  SUN PHARMA  DECCAN HEALTH CARE  ALPA LAB  

Compare JUBILANT PHARMOVA With:   BERYL DRUGS  ANG LIFESCIENCES INDIA  SUN PHARMA  DECCAN HEALTH CARE  ALPA LAB  




Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today (Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 8-QTR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS